title: Greater impairments in cerebral artery compared with skeletal muscle feed artery endothelial function in a mouse model of increased large artery stiffness.
abstract: CONCLUSIONS
  Increased large artery stiffness is a hallmark of arterial dysfunction with advancing age and is also present in other disease conditions such as diabetes. Increased large artery stiffness is correlated with resistance artery dysfunction in humans. Using a mouse model of altered arterial elastin content, this is the first study to examine the cause-and-effect relationship between large artery stiffness and peripheral resistance artery function. Our results indicate that mice with genetically greater large artery stiffness have impaired cerebral artery endothelial function, but generally preserved skeletal muscle feed artery endothelial function. The mechanisms for impaired cerebral artery endothelial function are reduced nitric oxide bioavailability and increased oxidative stress. These findings suggest that interventions that target large artery stiffness may be important to reduce disease risk associated with cerebral artery dysfunction in conditions such as advancing age.
  Advancing age as well as diseases such as diabetes are characterized by both increased large artery stiffness and impaired peripheral artery function. It has been hypothesized that greater large artery stiffness causes peripheral artery dysfunction; however, a cause-and-effect relationship has not previously been established. We used elastin heterozygote mice (Eln(+/-) ) as a model of increased large artery stiffness without co-morbidities unrelated to the large artery properties. Aortic stiffness, measured by pulse wave velocity, was ∼35% greater in Eln(+/-) mice than in wild-type (Eln(+/+) ) mice (P = 0.04). Endothelium-dependent dilatation (EDD), assessed by the maximal dilatation to acetylcholine, was ∼40% lower in Eln(+/-) than Eln(+/+) mice in the middle cerebral artery (MCA, P < 0.001), but was similar between groups in the gastrocnemius feed arteries (GFA, P = 0.79). In the MCA, EDD did not differ between groups after incubation with the nitric oxide (NO) synthase inhibitor N(ω) -nitro-l-arginine methyl ester (P > 0.05), indicating that lower NO bioavailability contributed to the impaired EDD in Eln(+/-) mice. Superoxide production and content of the oxidative stress marker nitrotyrosine was higher in MCAs from Eln(+/-) compared with Eln(+/+) mice (P < 0.05). In the MCA, after incubation with the superoxide scavenger TEMPOL, maximal EDD improved by ∼65% in Eln(+/-) (P = 0.002), but was unchanged in Eln(+/+) mice (P = 0.17). These results indicate that greater large artery stiffness has a more profound effect on endothelial function in cerebral arteries compared with skeletal muscle feed arteries. Greater large artery stiffness can cause cerebral artery endothelial dysfunction by reducing NO bioavailability and increasing oxidative stress.
authors: Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
authors: Ashley E
authors: AE
authors: Walker
authors: Grant D
authors: GD
authors: Henson
authors: Kelly D
authors: KD
authors: Reihl
authors: R Garrett
authors: RG
authors: Morgan
authors: Parker S
authors: PS
authors: Dobson
authors: Elizabeth I
authors: EI
authors: Nielson
authors: Jing
authors: J
authors: Ling
authors: Robert P
authors: RP
authors: Mecham
authors: Dean Y
authors: DY
authors: Li
authors: Lisa A
authors: LA
authors: Lesniewski
authors: Anthony J
authors: AJ
authors: Donato
mesh_terms: D000818:Animals; D002536:Cerebral Arteries / Q000187:drug effects / Q000503:physiopathology*; D004195:Disease Models, Animal; D004549:Elastin / Q000235:genetics / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D051379:Mice; D018345:Mice, Knockout; D018482:Muscle, Skeletal / Q000098:blood supply*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology; D059289:Vascular Stiffness / Q000187:drug effects / Q000502:physiology*; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology
chemical_list: D004791:Enzyme Inhibitors; D004549:Elastin; D019331:NG-Nitroarginine Methyl Ester; D007213:Indomethacin
references: Stroke. 2012 Oct;43(10):2631-6
references: 22923446
references: Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H672-9
references: 22821989
references: Hypertension. 1998 Jan;31(1):125-30
references: 9449403
references: J Physiol. 2003 Oct 1;552(Pt 1):185-95
references: 12844513
references: Br J Pharmacol. 2000 Jul;130(5):963-74
references: 10882379
references: J Appl Physiol (1985). 2008 Nov;105(5):1652-60
references: 18772322
references: Age (Dordr). 2014 Apr;36(2):559-69
references: 24065292
references: Ultrasound Med Biol. 1999 Feb;25(2):181-8
references: 10320307
references: Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1770-80
references: 21169401
references: Circ Res. 2003 Feb 21;92(3):322-9
references: 12595345
references: Am J Hypertens. 2008 Dec;21(12):1288-91
references: 18846043
references: Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H654-66
references: 24414067
references: Physiol Rep. 2014 Mar 27;2(3):e00268
references: 24760522
references: Circulation. 2005 Dec 13;112(24):3722-8
references: 16330686
references: Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1662-72
references: 12234821
references: Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1209-17
references: 15863465
references: Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H425-32
references: 19465546
references: Hypertension. 2005 Jul;46(1):200-4
references: 15911742
references: J Appl Physiol (1985). 2002 Nov;93(5):1685-90
references: 12381754
references: Hypertension. 1997 May;29(5):1140-7
references: 9149679
references: Am J Hum Genet. 2002 Jul;71(1):30-44
references: 12016585
references: Brain. 2011 Nov;134(Pt 11):3398-407
references: 22075523
references: J Vasc Res. 2012;49(6):463-78
references: 22796658
references: J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):9-20
references: 19211548
references: Hypertension. 2006 Dec;48(6):1072-9
references: 17043164
references: Hypertension. 1993 Jun;21(6 Pt 1):816-26
references: 8500863
references: Arterioscler Thromb Vasc Biol. 2005 May;25(5):995-1001
references: 15718491
references: Am J Physiol. 1990 Nov;259(5 Pt 2):H1455-62
references: 2122745
references: Antioxid Redox Signal. 2008 Sep;10(9):1631-74
references: 18598143
references: J Physiol. 2011 Sep 15;589(Pt 18):4545-54
references: 21746786
references: IEEE Trans Biomed Eng. 2005 Oct;52(10):1764-70
references: 16235662
references: Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1914-9
references: 19395552
references: Clin Exp Hypertens. 2008 Oct;30(7):616-27
references: 18855265
references: Exp Physiol. 2005 Jul;90(4):463-8
references: 15890799
references: Circulation. 2003 Sep 9;108(10):1253-8
references: 12874194
references: Circulation. 2003 Jan 7;107(1):139-46
references: 12515756
references: J Appl Physiol (1985). 2007 Oct;103(4):1172-9
references: 17626832
references: J Neurochem. 2013 Dec;127(5):691-700
references: 23745722
references: Rejuvenation Res. 2008 Feb;11(1):97-112
references: 18173368
references: J Hypertens. 2006 May;24(5):875-80
references: 16612249
references: Circulation. 1997 Jul 1;96(1):308-15
references: 9236450
references: Nature. 1998 May 21;393(6682):276-80
references: 9607766
references: J Clin Invest. 2003 Nov;112(9):1419-28
references: 14597767
references: Circulation. 2006 Feb 7;113(5):657-63
references: 16461838
references: Aging Cell. 2013 Oct;12(5):772-83
references: 23714110
references: Circulation. 1997 Nov 18;96(10):3610-6
references: 9396462